Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and endometrial intra-epithelial neoplasia: a multi-center Endometrial Cancer Molecularly Targeted Therapy (ECMT2) Consortium study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 08, 2026
Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2).
Journal: Gynecologic oncology
Published: April 21, 2025
HER2 expression in an endometrial cancer cohort.
Journal: Gynecologic oncology
Published: April 12, 2025
A working group report from the 2024 National Cancer Institute / Gynecologic Cancer Steering Committee endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy era.
Journal: Journal of the National Cancer Institute
Published: January 09, 2025
The advent of immune checkpoint inhibition for the treatment of patients with primary advanced or recurrent dMMR/MSI high endometrial cancer in 2025.
Journal: Current opinion in obstetrics & gynecology
Published: November 29, 2024
The missing data: A review of gender and sex disparities in research.
Journal: Cancer
Published: November 14, 2024
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study.
Journal: Gynecologic oncology
Published: November 14, 2024
Very low-carbohydrate ketogenic diet in treatment-naïve women with endometrial cancer and overweight: a randomized feasibility study.
Journal: Nature communications
Published: October 21, 2024
Race- associated molecular differences in uterine serous carcinoma.
Journal: Frontiers in oncology
Published: June 06, 2024
Disseminated Actinomyces Case Report: A Mimicker of Advanced Ovarian Malignancy.
Journal: Case reports in oncology
Published: May 17, 2024
SPL-108 mitigates metastasis and chemoresistance in tubo-ovarian carcinoma.
Journal: Translational oncology
Published: March 28, 2024
Molecular testing for endometrial cancer: An SGO clinical practice statement.
Journal: Gynecologic oncology
Published: September 06, 2022
Last Updated: 09/26/2026